Literature DB >> 8358542

Interaction between the effects of 5-hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog.

S J McAuliffe1, H M Snow, B Cox, C C Smith, M I Noble.   

Abstract

1. The interaction between adrenaline and 5-hydroxytryptamine (5-HT) has been quantitated on the rate of thrombus formation, in the stenosed coronary artery with damaged endothelium of the anaesthetized dog. 2. Changes in the plasma concentration of adrenaline were produced by varying the rate of an intravenous infusion of adrenaline and in the effects of 5-HT, by intravenous injections of the selective 5-HT2 receptor antagonist, ICI 170809. 3. Increases in the plasma concentration of adrenaline, which did not cause significant changes in blood pressure and heart rate, increased the rate of thrombus formation. 4. Antagonism of the 5-HT2 receptor by ICI 170809, in the absence of an infusion of adrenaline, abolished thrombus formation (mean ED50 0.41 microgram kg-1, i.v.). 5. The effects of adrenaline were non-competitively antagonized by ICI 170809; maximum effects were obtained in the dose-range 50-200 micrograms kg-1, i.v., when the mean dose-ratio increase in adrenaline required to restore equivalent rates of thrombus formation was 39 fold. 6. These results are consistent with a synergism between adrenaline and 5-HT and emphasize the importance of both on thrombus formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358542      PMCID: PMC2175684          DOI: 10.1111/j.1476-5381.1993.tb13583.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

Authors:  J D Folts; E B Crowell; G G Rowe
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

2.  Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

Authors:  J A Grant; M C Scrutton
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

3.  Functional expression of the amplification reaction between serotonin and epinephrine on platelets.

Authors:  F De Clerck; B Xhonneux; D de Chaffoy de Courcelles
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

4.  Platelet aggregation in whole blood: is the response to adrenaline, 5-hydroxytryptamine and PAF a direct consequence of stimulation by these agonists?

Authors:  A C Petty; M C Scrutton
Journal:  Thromb Res       Date:  1989-04-15       Impact factor: 3.944

5.  Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease.

Authors:  J W Haerem
Journal:  Atherosclerosis       Date:  1972 Mar-Apr       Impact factor: 5.162

6.  Evidence for functional 5-HT2 receptor sites on human blood platelets.

Authors:  F De Clerck; B Xhonneux; J Leysen; P A Janssen
Journal:  Biochem Pharmacol       Date:  1984-09-01       Impact factor: 5.858

7.  The distribution of catecholamines between platelets and plasma in normal human subjects.

Authors:  C C Smith; L D Curtis; A P Delamothe; B N Prichard; D J Betteridge
Journal:  Clin Sci (Lond)       Date:  1985-07       Impact factor: 6.124

8.  5-hydroxytryptamine and platelet aggregation.

Authors:  F F De Clerck; A G Herman
Journal:  Fed Proc       Date:  1983-02

9.  Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.

Authors:  J H Ashton; C R Benedict; C Fitzgerald; S Raheja; A Taylor; W B Campbell; L M Buja; J T Willerson
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

10.  Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.

Authors:  J H Ashton; P Golino; J M McNatt; L M Buja; J T Willerson
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

View more
  2 in total

1.  Comparative effects of anti-platelet agents as adjuncts to tissue plasminogen activator in a dog model of occlusive coronary thrombosis.

Authors:  S J McAuliffe; J A Moors; H B Jones
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

2.  The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.

Authors:  N A Alarayyed; B R Graham; B N Prichard; C C Smith
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.